Annual Working Capital
$145.00 M
+$27.31 M+23.20%
31 December 2023
Summary:
Lexicon Pharmaceuticals annual working capital is currently $145.00 million, with the most recent change of +$27.31 million (+23.20%) on 31 December 2023. During the last 3 years, it has risen by +$34.09 million (+30.73%). LXRX annual working capital is now -64.59% below its all-time high of $409.44 million, reached on 31 December 2015.LXRX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$232.56 M
-$60.41 M-20.62%
30 September 2024
Summary:
Lexicon Pharmaceuticals quarterly working capital is currently $232.56 million, with the most recent change of -$60.41 million (-20.62%) on 30 September 2024. Over the past year, it has increased by +$41.45 million (+21.69%). LXRX quarterly working capital is now -43.20% below its all-time high of $409.44 million, reached on 31 December 2015.LXRX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LXRX Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +23.2% | +21.7% |
| 3 y3 years | +30.7% | +159.1% |
| 5 y5 years | +6.2% | -27.0% |
LXRX Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +117.1% | -31.9% | +384.1% |
| 5 y | 5 years | -46.8% | +117.1% | -31.9% | +440.6% |
| alltime | all time | -64.6% | +7074.7% | -43.2% | >+9999.0% |
Lexicon Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $232.56 M(-20.6%) |
| June 2024 | - | $292.97 M(-14.1%) |
| Mar 2024 | - | $341.25 M(+135.3%) |
| Dec 2023 | $145.00 M(+23.2%) | $145.00 M(-24.1%) |
| Sept 2023 | - | $191.11 M(-19.6%) |
| June 2023 | - | $237.61 M(+166.5%) |
| Mar 2023 | - | $89.17 M(-24.2%) |
| Dec 2022 | $117.69 M(+76.2%) | $117.69 M(-2.4%) |
| Sept 2022 | - | $120.62 M(+151.1%) |
| June 2022 | - | $48.04 M(-30.9%) |
| Mar 2022 | - | $69.53 M(+4.1%) |
| Dec 2021 | $66.80 M(-39.8%) | $66.80 M(-25.6%) |
| Sept 2021 | - | $89.76 M(-0.8%) |
| June 2021 | - | $90.44 M(-15.0%) |
| Mar 2021 | - | $106.42 M(-4.1%) |
| Dec 2020 | $110.91 M(-59.3%) | $110.91 M(+157.8%) |
| Sept 2020 | - | $43.02 M(-71.1%) |
| June 2020 | - | $148.63 M(-29.7%) |
| Mar 2020 | - | $211.29 M(-22.4%) |
| Dec 2019 | $272.41 M(+99.5%) | $272.41 M(-14.5%) |
| Sept 2019 | - | $318.77 M(+218.8%) |
| June 2019 | - | $99.99 M(-15.7%) |
| Mar 2019 | - | $118.61 M(-13.2%) |
| Dec 2018 | $136.57 M(-36.9%) | $136.57 M(+5.2%) |
| Sept 2018 | - | $129.85 M(-6.5%) |
| June 2018 | - | $138.85 M(-19.6%) |
| Mar 2018 | - | $172.78 M(-20.2%) |
| Dec 2017 | $216.51 M(+12.0%) | $216.51 M(+153.8%) |
| Sept 2017 | - | $85.29 M(-25.2%) |
| June 2017 | - | $114.01 M(-19.7%) |
| Mar 2017 | - | $142.03 M(-26.5%) |
| Dec 2016 | $193.23 M(-52.8%) | $193.23 M(-15.5%) |
| Sept 2016 | - | $228.62 M(-25.9%) |
| June 2016 | - | $308.46 M(-16.7%) |
| Mar 2016 | - | $370.21 M(-9.6%) |
| Dec 2015 | $409.44 M(+26.4%) | $409.44 M(+72.7%) |
| Sept 2015 | - | $237.15 M(-12.2%) |
| June 2015 | - | $270.23 M(-8.8%) |
| Mar 2015 | - | $296.38 M(-8.5%) |
| Dec 2014 | $324.02 M(+181.1%) | $324.02 M(+644.0%) |
| Sept 2014 | - | $43.55 M(-32.8%) |
| June 2014 | - | $64.77 M(-26.2%) |
| Mar 2014 | - | $87.73 M(-23.9%) |
| Dec 2013 | $115.26 M(-45.8%) | $115.26 M(-15.1%) |
| Sept 2013 | - | $135.76 M(-4.5%) |
| June 2013 | - | $142.17 M(-24.8%) |
| Mar 2013 | - | $189.08 M(-11.1%) |
| Dec 2012 | $212.65 M | $212.65 M(+7.9%) |
| Sept 2012 | - | $197.03 M(-9.1%) |
| June 2012 | - | $216.72 M(-9.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $238.05 M(-10.0%) |
| Dec 2011 | $264.40 M(+29.6%) | $264.40 M(+97.1%) |
| Sept 2011 | - | $134.18 M(-14.0%) |
| June 2011 | - | $155.97 M(-12.7%) |
| Mar 2011 | - | $178.71 M(-12.4%) |
| Dec 2010 | $203.96 M(+71.8%) | $203.96 M(-8.4%) |
| Sept 2010 | - | $222.67 M(-12.7%) |
| June 2010 | - | $255.01 M(-7.1%) |
| Mar 2010 | - | $274.59 M(+131.3%) |
| Dec 2009 | $118.73 M(+34.9%) | $118.73 M(+42.1%) |
| Sept 2009 | - | $83.54 M(-0.1%) |
| June 2009 | - | $83.60 M(+2.0%) |
| Mar 2009 | - | $81.93 M(-6.9%) |
| Dec 2008 | $87.99 M(-61.6%) | $87.99 M(-17.3%) |
| Sept 2008 | - | $106.42 M(-15.1%) |
| June 2008 | - | $125.29 M(-14.6%) |
| Mar 2008 | - | $146.68 M(-36.0%) |
| Dec 2007 | $229.30 M(+479.3%) | $229.30 M(-5.3%) |
| Sept 2007 | - | $242.06 M(+298.2%) |
| June 2007 | - | $60.79 M(+181.2%) |
| Mar 2007 | - | $21.61 M(-45.4%) |
| Dec 2006 | $39.59 M(-18.5%) | $39.59 M(+287.3%) |
| Sept 2006 | - | $10.22 M(-47.2%) |
| June 2006 | - | $19.37 M(-47.8%) |
| Mar 2006 | - | $37.09 M(-23.7%) |
| Dec 2005 | $48.58 M(-19.1%) | $48.58 M(+3.3%) |
| Sept 2005 | - | $47.05 M(+19.2%) |
| June 2005 | - | $39.48 M(-7.4%) |
| Mar 2005 | - | $42.62 M(-29.0%) |
| Dec 2004 | $60.04 M(-57.0%) | $60.04 M(-16.1%) |
| Sept 2004 | - | $71.57 M(-13.4%) |
| June 2004 | - | $82.69 M(-33.6%) |
| Mar 2004 | - | $124.52 M(-10.9%) |
| Dec 2003 | $139.74 M(+25.0%) | $139.74 M(+12.7%) |
| Sept 2003 | - | $123.99 M(+45.2%) |
| June 2003 | - | $85.40 M(-13.9%) |
| Mar 2003 | - | $99.20 M(-11.3%) |
| Dec 2002 | $111.83 M(-24.3%) | $111.83 M(+4.3%) |
| Sept 2002 | - | $107.17 M(-11.5%) |
| June 2002 | - | $121.16 M(-7.5%) |
| Mar 2002 | - | $130.91 M(-11.3%) |
| Dec 2001 | $147.66 M(-24.2%) | $147.66 M(-13.8%) |
| Sept 2001 | - | $171.37 M(-5.9%) |
| June 2001 | - | $182.07 M(-2.9%) |
| Mar 2001 | - | $187.57 M(-3.7%) |
| Dec 2000 | $194.80 M(+9538.8%) | $194.80 M(-3.6%) |
| Sept 2000 | - | $202.03 M(-0.3%) |
| June 2000 | - | $202.61 M(<-9900.0%) |
| Mar 2000 | - | -$541.90 K |
| Dec 1999 | $2.02 M | - |
FAQ
- What is Lexicon Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Lexicon Pharmaceuticals?
- What is Lexicon Pharmaceuticals annual working capital year-on-year change?
- What is Lexicon Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Lexicon Pharmaceuticals?
- What is Lexicon Pharmaceuticals quarterly working capital year-on-year change?
What is Lexicon Pharmaceuticals annual working capital?
The current annual working capital of LXRX is $145.00 M
What is the all time high annual working capital for Lexicon Pharmaceuticals?
Lexicon Pharmaceuticals all-time high annual working capital is $409.44 M
What is Lexicon Pharmaceuticals annual working capital year-on-year change?
Over the past year, LXRX annual working capital has changed by +$27.31 M (+23.20%)
What is Lexicon Pharmaceuticals quarterly working capital?
The current quarterly working capital of LXRX is $232.56 M
What is the all time high quarterly working capital for Lexicon Pharmaceuticals?
Lexicon Pharmaceuticals all-time high quarterly working capital is $409.44 M
What is Lexicon Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, LXRX quarterly working capital has changed by +$41.45 M (+21.69%)